This compoundutilizes a maleimide moiety, which specifically targets the singlefree cysteine residue of albumin at position 34.28 We have recently reported on the first maleimide-bearingplatinum(IV) complexes.29,30 Here, especially, theoxaliplatin derivatives not only showed excellent reduction propertiesand tumor accumulation but also promising antitumor activity in vivo. The gene discussed is ALB; the disease is neoplasm.